Last reviewed · How we verify

Methylene Blue MMX® — Competitive Intelligence Brief

Methylene Blue MMX® (Methylene Blue MMX®) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Mitochondrial function enhancer / Antioxidant. Area: Neurology.

phase 3 Mitochondrial function enhancer / Antioxidant Mitochondrial electron transport chain; cytochrome c oxidase Neurology Small molecule Live · refreshed every 30 min

Target snapshot

Methylene Blue MMX® (Methylene Blue MMX®) — Cosmo Technologies Ltd. Methylene Blue MMX is a modified-release formulation of methylene blue that acts as a mitochondrial function enhancer and antioxidant to improve cognitive and neurological outcomes.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Methylene Blue MMX® TARGET Methylene Blue MMX® Cosmo Technologies Ltd phase 3 Mitochondrial function enhancer / Antioxidant Mitochondrial electron transport chain; cytochrome c oxidase

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Mitochondrial function enhancer / Antioxidant class)

  1. Cosmo Technologies Ltd · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Methylene Blue MMX® — Competitive Intelligence Brief. https://druglandscape.com/ci/methylene-blue-mmx. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: